Rani Therapeutics Holdings (RANI) EBITDA Margin (QoQ) (2020 - 2026)

Rani Therapeutics Holdings (RANI) EBITDA Margin (QoQ) (2020 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.53 Bn	130.68 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.34 Bn	78.35 Bn	3.93 Bn
3	Argenx Se	64.67 Bn	59.48 Bn	1.37 Bn
4	Moderna	59.04 Bn	53.90 Bn	52.00 Mn
5	BeOne Medicines	42.03 Bn	36.94 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.78 Bn	27.47 Bn	992.69 Mn
7	BioNTech SE	27.81 Bn	9.42 Bn	668.28 Mn
8	Insmed	27.21 Bn	26.05 Bn	358.27 Mn
9	Royalty Pharma	26.99 Bn	26.15 Bn	-
10	Rani Therapeutics Holdings	163.53 Mn	163.53 Mn	-

Download Data